11.06.2019
Diagnostics
$744,580.00
36 months
Developing a point of care assay for determination of serum neutralizing anti-drug antibodies and drug levels
The goal of this project is to develop assays that will allow the prediction of a CD patient's response to therapeutics and enable optimization of treatment without delay for optimal treatment outcomes for CD patients.